Phio Pharmaceuticals | 8-K:重大事件
Phio Pharmaceuticals | S-3:特定交易注册声明
Phio Pharmaceuticals | RW:注册提款请求
Phio Pharmaceuticals | S-3:特定交易注册声明
Phio Pharmaceuticals | 424B5:募资说明书
Phio Pharmaceuticals | 8-K:重大事件
Phio Pharmaceuticals | 8-K:重大事件
Phio Pharmaceuticals | 10-Q:季度报表
Phio Pharmaceuticals | DEFA14A:其他
Phio Pharmaceuticals | ARS:年度报告
Phio Pharmaceuticals | DEF 14A:股东委托书决议
Phio Pharmaceuticals | PRE 14A:并购重组委托声明
Phio Pharmaceuticals | 8-K:重大事件
Phio Pharmaceuticals | 10-K:年度报表
Phio Pharmaceuticals | 4:持股变动声明-高管 Kontulis Caitlin
Phio Pharmaceuticals | 4:持股变动声明-高管 Bitterman Robert J
Phio Pharmaceuticals | 4:持股变动声明-高管 Bitterman Robert J
Phio Pharmaceuticals | 4:持股变动声明-高管 Kontulis Caitlin
Phio Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%)等
Phio Pharmaceuticals | 8-K:重大事件
暂无数据